Tin-Based Antitumour Drugs / Nato ASI Subseries H: Bd.37 (PDF)
(Sprache: Englisch)
Whereas platinum compounds are already clinically used as anticancer agents, tin compounds exhibiting high enough antitumour activity have not yet been found to enter the clinical phase. This is paradoxical with the observation that 50% of the tested...
sofort als Download lieferbar
eBook (pdf)
53.49 €
26 DeutschlandCard Punkte sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Tin-Based Antitumour Drugs / Nato ASI Subseries H: Bd.37 (PDF)“
Whereas platinum compounds are already clinically used as anticancer agents, tin compounds exhibiting high enough antitumour activity have not yet been found to enter the clinical phase. This is paradoxical with the observation that 50% of the tested compounds showed some activity, which is an abnormally high percentage. This is probably due to the fact that research of this type with tin compounds started more recently than with platinum compounds and that almost exclusively known compounds coming from laboratories working in the field of organotin compounds have been blindly tested. Some research directed towards the development of organotin compounds with some biologically favourable properties, for instance derivatives with hydrophilic or lipophilic, or with increased bio-availability characteristics, has started only recently. We thought that was now the appropriate time to bring together experts from different disciplines (biochemists, pharmacologists, organotin chemists, oncologists, etc.) working in the field of tin-based antitumour drugs, to contribute to the critical assessment of existing knowledge in this new important topic, to identify the directions for future research and to promote close working relations between the different countries and professional experiences gathered in this workshop.
Bibliographische Angaben
- 2013, 1990, 226 Seiten, Englisch
- Herausgegeben: Marcel Gielen
- Verlag: Springer Berlin Heidelberg
- ISBN-10: 3642741916
- ISBN-13: 9783642741913
- Erscheinungsdatum: 29.06.2013
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Größe: 24 MB
- Ohne Kopierschutz
- Vorlesefunktion
Sprache:
Englisch
Kommentar zu "Tin-Based Antitumour Drugs / Nato ASI Subseries H: Bd.37"
0 Gebrauchte Artikel zu „Tin-Based Antitumour Drugs / Nato ASI Subseries H: Bd.37“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Tin-Based Antitumour Drugs / Nato ASI Subseries H: Bd.37".
Kommentar verfassen